🔗 Share this article

This year's Nobel Prize in medical science was awarded for revolutionary discoveries that illuminate how the body's defense network attacks harmful infections while protecting the healthy tissues.

Three esteemed scientists—Japan's Prof. Sakaguchi and American scientists Dr. Brunkow and Fred Ramsdell—share this accolade.

Their work uncovered specialized "sentinels" within the immune system that eliminate rogue immune cells that could harming the body.

These findings are now paving the way for new treatments for autoimmune diseases and malignancies.

The laureates will share a prize fund worth 11 million SEK.

Crucial Findings

"Their research has been essential for comprehending how the body's defenses operates and the reason we do not all develop serious autoimmune diseases," stated the chair of the award panel.

This team's studies address a core question: In what way does the immune system protect us from numerous infections while keeping our own tissues unharmed?

The body's protection system employs immune cells that scan for signs of infection, including viruses and germs it has never encountered.

These defenders utilize detectors—known as receptors—that are generated by chance in countless combinations.

This gives the immune system the capacity to combat a wide array of threats, but the unpredictability of the mechanism inevitably creates immune cells that can attack the body.

Protectors of the Immune System

Scientists earlier understood that a portion of these problematic white blood cells were eliminated in the immune organ—where white blood cells mature.

The latest Nobel Prize honors the identification of T-reg cells—known as the immune system's "peacekeepers"—which travel through the system to disarm other defenders that assault the body's own tissues.

We know that this mechanism fails in autoimmune diseases such as juvenile diabetes, multiple sclerosis, and RA.

The Nobel panel stated, "The discoveries have established a novel area of investigation and accelerated the development of new treatments, for example for tumors and autoimmune diseases."

In cancer, T-regs block the system from fighting the growth, so studies are focused on reducing their quantity.

For autoimmune diseases, experiments are testing increasing regulatory T-cells so the organism is no longer being harmed. A similar approach could also be effective in reducing the chances of transplanted organ failure.

Innovative Studies

Prof Sakaguchi, of Osaka University, conducted tests on rodents that had their thymus removed, causing autoimmune disease.

The researcher showed that injecting defense cells from other animals could prevent the disease—implying there was a mechanism for preventing defenders from attacking the host.

Dr. Brunkow, from the Institute for Systems Biology in Seattle, and Fred Ramsdell, now at a biotech firm in San Francisco, were studying an genetic immune disorder in rodents and humans that resulted in the identification of a genetic factor critical for how regulatory T-cells operate.

"Their groundbreaking research has uncovered how the immune system is controlled by T-reg cells, preventing it from mistakenly targeting the body's own tissues," said a prominent biological science expert.

"This research is a striking example of how fundamental biological research can have far-reaching implications for public health."